Triofan Antitussif Noscapine, comprimés enrobés
7680688110012
CH-68811
Tabletten
Associated product:
TRIOFAN Antitussif Noscapine cpr 20 pce
1 / 3
google
Article details
- Package size
- 20
- Selling units
- 20
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
13.25 MG | Substance | WIIS |
|
(N/A)
|
80.707 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
64.826 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.15 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
0.008 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
Verfora SA
1752 Villars-sur-Glâne
Authorization information
- Swissmedic authorization number
- 68811
- Drug name
- Triofan Antitussif Noscapine, comprimés enrobés
- Galenic form
- UEBT
- ATC Code
- R05DA07
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 08/05/2023
- Authorization expiration date
- 07/05/2028
- IT Number
- 03.01.2.
- Domain
- Human medicine
Package details
- Description (FR)
- TRIOFAN Antitussif Noscapine cpr 20 pce
- Description (DE)
- TRIOFAN Hustenstiller Noscapin Tabl 20 Stk
- Market launch
- 08/05/2023
- Narcotic (BTM)
- No